TIDMKNOS

RNS Number : 4557B

Kainos Group plc

20 September 2018

20 September 2018

Kainos Group plc

("Kainos" or the "Company")

Results of Annual General Meeting

The 2018 Annual General Meeting ("AGM") of Kainos Group plc took place today at 9.30am.

All resolutions proposed at the AGM were carried unanimously on a show of hands. The full text of each of the resolutions is set out in the Notice of AGM, a copy of which is available on the Kainos website www.kainos.com. Details of the proxy votes received on each resolution will also shortly be made available on the Kainos website.

In accordance with UK Listing Rule 9.6.2R copies of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM

No other business was conducted at the meeting.

Kainos Group Limited Legal Entity Identifier: 213800H2PQMIF3OVZY47

Classification: 3.1 - Additional regulated information

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGEALNEAFAPEFF

(END) Dow Jones Newswires

September 20, 2018 10:15 ET (14:15 GMT)

Kainos (LSE:KNOS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Kainos Charts.
Kainos (LSE:KNOS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Kainos Charts.